Crossmark

Radiomics-enhanced early regression index for predicting treatment response in rectal cancer: a multi-institutional 0.35 T MRI-guided radiotherapy study

Crossref DOI link: https://doi.org/10.1007/s11547-024-01761-7

Published Online: 2024-03-21

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Boldrini, Luca

Chiloiro, Giuditta

Cusumano, Davide

Yadav, Poonam

Yu, Gao

Romano, Angela

Piras, Antonio

Votta, Claudio

Placidi, Lorenzo

Broggi, Sara

Catucci, Francesco

Lenkowicz, Jacopo

Indovina, Luca

Bassetti, Michael F.

Yang, Yingli

Fiorino, Claudio

Valentini, Vincenzo

Gambacorta, Maria Antonietta
License Information

Text and Data Mining valid from 2024-03-21

Version of Record valid from 2024-03-21
More Information

Article History

Received: 15 June 2023

Accepted: 3 January 2024

First Online: 21 March 2024

Declarations

:

: The authors have not disclosed any competing interests.

: This article does not contain any studies with human participants or animals performed by any of the authors.

Document is current

Any future updates will be listed below